tiprankstipranks
Trending News
More News >
Greenwich Lifesciences, Inc. (GLSI)
NASDAQ:GLSI
US Market

Greenwich LifeSciences (GLSI) Income Statement

Compare
399 Followers

Greenwich LifeSciences Income Statement

Last quarter (Q3 2025), Greenwich LifeSciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Greenwich LifeSciences's net income was $-4.15M. See Greenwich LifeSciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -3.61K$ -3.61K$ -3.61K$ -3.61K$ -3.61K
Operating Expenses
$ 16.01M$ 9.33M$ 8.04M$ 4.60M$ 1.86M
Depreciation and Amortization
$ 3.61K$ 3.61K$ 3.61K$ 3.61K$ 3.61K
EBITDA
$ -15.79M$ -9.32M$ -8.04M$ -4.59M$ -1.86M
Operating Income
$ -16.01M$ -9.33M$ -8.04M$ -4.60M$ -1.86M
Other Income/Expenses
$ 223.01K$ 436.06K$ 215.02K$ 27.37K$ 832.00
Pretax Income
$ -15.79M$ -8.89M$ -7.83M$ -4.57M$ -1.86M
Net Income
$ -15.79M$ -8.89M$ -7.83M$ -4.57M$ -1.86M
Per Share Metrics
Basic EPS
$ -1.21$ -0.69$ -0.61$ -0.35$ -0.15
Diluted EPS
$ -1.21$ -0.69$ -0.61$ -0.35$ -0.15
Weighted Average Shares Outstanding
13.01M 12.85M 12.91M 12.94M 12.70M
Weighted Average Shares Outstanding (Diluted)
13.01M 12.85M 12.91M 12.94M 12.70M
Currency in USD

Greenwich LifeSciences Earnings and Revenue History